Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Clinical trial NCT06975371 · COMPLETED

Trial details

NCT number: NCT06975371
Sponsor: Daiichi Sankyo
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced/Metastatic HER2-negative Breast Cancer

Start date: 2025-04-14
Primary completion: 2025-05-08
Enrollment: 1415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.